Ads
related to: janssen xarelto assistance application program for patients- Save on XARELTO®
XARELTO withMe Savings Program.
2024 Program Requirements Apply
- XARELTO® Side Effects
Review The Side Effects Of XARELTO®
Before Deciding To Start Treatment
- Common XARELTO® Questions
Read Answers To Frequently Asked
Questions About XARELTO®
- Save with XARELTO withMe
Get Information on XARELTO withMe
Patient Support Program
- Personal Discussion Guide
Fill Out A Personalized Discussion
Guide To Share With Your Doctor
- Important Safety Info
Read The Most Important Safety Info
You Should Know About XARELTO®
- Save on XARELTO®
Search results
Results From The WOW.Com Content Network
Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]
In November 2021, Pfizer submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization for the co-packaged medication. [ 68 ] [ 69 ] [ 70 ] The authorization was granted in December 2021, for people aged twelve years of age or older who are infected with COVID‑19 and are at risk.
Health-care giant Johnson & Johnson recently released a press statement that said that the FDA has turned down its bid to receive approval to treat patients with acute coronary syndrome (ACS) with ...
Expanded access or compassionate use is the use of an unapproved drug or medical device under special forms of investigational new drug applications (IND) or IDE application for devices, outside of a clinical trial, by people with serious or life-threatening conditions who do not meet the enrollment criteria for the clinical trial in progress.
The Janssen COVID‑19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, [1] is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, [24] and its Belgian parent company Janssen Pharmaceuticals, [25] a subsidiary of American company Johnson & Johnson.
Created Date: 1/13/2010 4:39:51 PM
Ads
related to: janssen xarelto assistance application program for patients